• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form F-10POS filed by The Valens Company Inc.

    1/17/23 10:51:15 AM ET
    $VLNS
    Get the next $VLNS alert in real time by email
    F-10POS 1 tm233351d1_f10pos.htm F-10POS

     

    Registration No. 333-263941    

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
     

    WASHINGTON, D.C. 20549 

     

    POST-EFFECTIVE AMENDMENT NO. 1 TO

    FORM F-10 

     

    REGISTRATION STATEMENT
    UNDER THE SECURITIES ACT OF 1933
     

     

    THE VALENS COMPANY INC. 

    (Exact name of Registrant as specified in its charter)

     

    ​ Canada ​ ​ 2833 ​ ​ N/A ​
    ​ (Province or other jurisdiction of
    incorporation or organization)
    ​ ​ (Primary Standard Industrial
    Classification Code Number)
    ​ ​ (I.R.S. Employer
    Identification Number, if applicable)
    ​

     

    230 Carion Road
    Kelowna, BC, Canada V4V 2K5
    (778) 755-0052
     

    (Address and telephone number of Registrant’s principal executive offices)

     

    CT Corporation System

    28 Liberty Street

    New York, New York 10005

    Telephone: (212) 894-8940

    (Name, address, including zip code, and telephone number, including area code, of agent for service in the United States)

     

    Copies to: 

     

    Zachary George
    Chief Executive Officer
    SNDL Inc.

    #300, 919 - 11 Avenue SW

    Calgary, AB T2R 1P3

    (403) 948-5227

    ​

    Stacie S. Aarestad

    Ryan M. Rourke Reed

    Foley Hoag LLP

    155 Seaport Boulevard

    Boston, Massachusetts 02210

    (617) 832-1000

     

    Approximate date of commencement of proposed sale to the public:
    Not applicable

    Province of Ontario, Canada 

    (Principal jurisdiction regulating this offering)

     

      It is proposed that this filing shall become effective (check appropriate box below):
       
      A. x upon filing with the Commission, pursuant to Rule 467(a) (if in connection with an offering being made contemporaneously in the United States and Canada).
         
      B.  ¨ at some future date (check appropriate box below)
         
        1. ¨ pursuant to Rule 467(b) on ( ) at ( ) (designate a time not sooner than seven calendar days after filing).
         
        2. ¨ pursuant to Rule 467(b) on ( ) at ( ) (designate a time seven calendar days or sooner after filing) because the securities regulatory authority in the review jurisdiction has issued a receipt or notification of clearance on ( ).
       
        3. ¨ pursuant to Rule 467(b) as soon as practicable after notification of the Commission by the Registrant or the Canadian securities regulatory authority of the review jurisdiction that a receipt or notification of clearance has been issued with respect hereto.
         
        4. ¨ after the filing of the next amendment to this form (if preliminary material is being filed).
       
      If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to the home jurisdiction’s shelf prospectus offering procedures, check the following box. ☒

     

     

     

     

     

      

    DEREGISTRATION OF SECURITIES

     

    On March 29, 2022, The Valens Company Inc. (the “Registrant”), filed with the Securities and Exchange Commission a registration statement on Form F-10, Registration No. 333-263941 (the “Registration Statement”) for the sale by the Registrant from time to time of up to an aggregate of US$150,000,000 of securities including common shares, debt securities, subscription receipts, warrants and units (collectively the “Securities”).

     

    Effective on January 17, 2023, SNDL Inc., a corporation existing under the laws of Alberta, Canada (“SNDL”) acquired all of the issued and outstanding common shares of the Registrant that SNDL or its affiliates did not already own, pursuant to an arrangement agreement dated August 22, 2022 by and among the Registrant and SNDL, in accordance with a court-approved plan of arrangement (the “Arrangement”) pursuant to Section 192 of the Canada Business Corporations Act. As a result of the Arrangement, the Registrant became a wholly owned subsidiary of SNDL.

     

    As a result of the Arrangement, the Registrant has terminated all offerings of securities pursuant to the Registration Statement. This Post-Effective Amendment No. 1 to the Registration Statement is being filed to deregister all of the Securities formerly issuable and registered under the Registration Statement and not otherwise sold by the Registrant as of the date that this Post-Effective Amendment No. 1 is filed. The Registration Statement is hereby amended, as appropriate, to reflect the deregistration of all such Securities.

     

     

     

     

    SIGNATURES 

     

    Pursuant to the requirements of the Securities Act of 1933, The Valens Company Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-10 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Toronto, Ontario, Canada, on January 17, 2023.

     

      THE VALENS COMPANY INC. 
       
      By: /s/ A. Tyler Robson
      Name: A. Tyler Robson
      Title: Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated and on the dates indicated:

     

    Signature ​ Title ​ Date
             
    /s/ A. Tyler Robson   ​ Chief Executive Officer ​ January 17, 2023
    A. Tyler Robson   (Principal Executive Officer)    
             
    /s/ Sunil Gandhi   ​ Chief Financial Officer ​ January 17, 2023
    Sunil Gandhi   (Principal Financial & Accounting Officer)    
             
    /s/ Zachary George   ​ Director ​ January 17, 2023
    Zachary George        
             
    /s/ James Keough   ​ Director ​ January 17, 2023
    James Keough        
             
    /s/ Kristine Dow   ​ Director ​ January 17, 2023
    Kristine Dow        

     

     

     

     

    AUTHORIZED REPRESENTATIVE 

     

    Pursuant to the requirements of Section 6(a) of the Securities Act of 1933, the undersigned has signed this Registration Statement, solely in its capacity as the duly authorized representative of The Valens Company Inc. in the United States, on January 17, 2023.

     

      GREEN ROADS, INC.
       
      By: /s/ Jeff Fallows
        Name: Jeff Fallows
        Title: President

     

     

     

    Get the next $VLNS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VLNS

    DatePrice TargetRatingAnalyst
    3/3/2022Market Perform → Underperform
    Raymond James
    More analyst ratings

    $VLNS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SNDL Completes Acquisition of The Valens Company

      Creates a low-cost vertically integrated Canadian company generating over a billion dollars in annualized pro forma revenue1 CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for tota

      1/17/23 8:32:00 AM ET
      $SNDL
      $VLNS
      Medicinal Chemicals and Botanical Products
      Health Care
    • THE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDL

      KELOWNA, BC, Jan. 3, 2023 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement

      1/3/23 1:19:00 PM ET
      $SNDL
      $VLNS
      Medicinal Chemicals and Botanical Products
      Health Care
    • The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

      KELOWNA, BC, Dec. 13, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on December 12, 2022. The Nasdaq determination is based on the Company meeting the continued listing requirement for mar

      12/13/22 6:30:00 PM ET
      $VLNS

    $VLNS
    SEC Filings

    See more
    • SEC Form 15-12G filed by The Valens Company Inc.

      15-12G - Valens Company, Inc. (0001859902) (Filer)

      1/27/23 8:12:07 AM ET
      $VLNS
    • SEC Form F-10POS filed by The Valens Company Inc.

      F-10POS - Valens Company, Inc. (0001859902) (Filer)

      1/17/23 10:51:15 AM ET
      $VLNS
    • SEC Form 6-K filed by The Valens Company Inc.

      6-K - Valens Company, Inc. (0001859902) (Filer)

      1/17/23 10:48:49 AM ET
      $VLNS

    $VLNS
    Leadership Updates

    Live Leadership Updates

    See more
    • The Valens Company Appoints New Board Chair and Provides an Update on its Annual General Meeting of Shareholders

      KELOWNA, BC, May 16, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS)) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of branded cannabis products, today announced that it has separated the roles of Chair and Chief Executive Officer (CEO) and appointed Andrew Cockwell as its new Chair of the Board, effective immediately.  This decision follows the Company's recent Nasdaq listing and its commitment to governance best practices including transparency and accountability. Tyler Robson has stepped down as Chair in full support of this decision and will remain on the Board and as the CEO of the Company.

      5/16/22 5:00:00 PM ET
      $VLNS

    $VLNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Valens Co downgraded by Raymond James

      Raymond James downgraded Valens Co from Market Perform to Underperform

      3/3/22 4:41:15 AM ET
      $VLNS

    $VLNS
    Financials

    Live finance-specific insights

    See more
    • Valens Semiconductor to Announce Second Quarter 2022 Financial Results on August 10, 2022

      HOD HASHARON, Israel,, July 20, 2022 /PRNewswire/ -- Valens Semiconductor (NYSE:VLN), a premier provider of high-speed connectivity solutions for the audio-video and automotive markets, today announced that it will release its second quarter 2022 financial results before the market opens on Wednesday, August 10, 2022. In conjunction with this announcement, Valens will host a conference call on Wednesday, August 10, 2022, at 8:30 a.m. Eastern Time (ET) to discuss its second quarter 2022 financial results and business outlook. To access this call, dial +1 (888) 642-5032 (U.S.), 0 (800) 917-5108 (UK), 03 918 0609 (Israel) or +972 3 918 0609 (all other locations). A live webcast of the conferenc

      7/20/22 8:00:00 AM ET
      $VLN
      $VLNS
      Semiconductors
      Technology
    • The Valens Company Reports Second Quarter Fiscal 2022 Financial Results

      Realized initial benefits of Integration Initiatives, with SG&A as a percent of revenue declining 908 basis points in Q2 2022 from Q1 2022 In five months, Valens has actioned $15 million in annual cost savings and has identified in excess of $5 million additional cost savings to be actioned over the next few quarters exceeding management's original $20 million target Achieved double-digit revenue growth in Green Roads, B2B, & International revenue segments. Provincial sales rebounded strongly in June with record monthly revenue Top 10 licensed producer in Canada, with a 3.2% market share for three months ending May 2022 Valens reiterates its objective of achieving positive adjusted EBITDA(2

      7/13/22 5:00:00 PM ET
      $VLNS
    • The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022

      KELOWNA, BC, July 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its second quarter 2022 financial results for the period ended May 31, 2022, on Wednesday, July 13, 2022, after market close. CONFERENCE CALL DETAILS The Company will host a conference call the following day, Thursday, July 14, 2022, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the financial results and business outlook. Participant Dial-In

      7/6/22 5:00:00 PM ET
      $VLNS